Clinical Trial Update: Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on deferoxamine for intracranial aneurysm-related subarachnoid hemorrhage across Phase 1 and Phase 2, status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracranial Aneurysm
• Subarachnoid Hemorrhage

Drugs mentioned

• Deferoxamine (deferoxamine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Intracranial Aneurysm, Subarachnoid Hemorrhage | Phase 1, Phase 2 | Status: UNKNOWN